These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20450350)

  • 1. Factors associated with mortality in transplant patients with invasive aspergillosis.
    Baddley JW; Andes DR; Marr KA; Kontoyiannis DP; Alexander BD; Kauffman CA; Oster RA; Anaissie EJ; Walsh TJ; Schuster MG; Wingard JR; Patterson TF; Ito JI; Williams OD; Chiller T; Pappas PG
    Clin Infect Dis; 2010 Jun; 50(12):1559-67. PubMed ID: 20450350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
    Baddley JW; Andes DR; Marr KA; Kauffman CA; Kontoyiannis DP; Ito JI; Schuster MG; Brizendine KD; Patterson TF; Lyon GM; Boeckh M; Oster RA; Chiller T; Pappas PG
    Med Mycol; 2013 Feb; 51(2):128-35. PubMed ID: 22680976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
    Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
    Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.
    Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA
    Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.
    Salman N; Törün SH; Budan B; Somer A
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):307-15. PubMed ID: 21417870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
    Upton A; Kirby KA; Carpenter P; Boeckh M; Marr KA
    Clin Infect Dis; 2007 Feb; 44(4):531-40. PubMed ID: 17243056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
    Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).
    Gioia F; Filigheddu E; Corbella L; Fernández-Ruiz M; López-Medrano F; Pérez-Ayala A; Aguado JM; Fariñas MC; Arnaiz F; Calvo J; Cifrian JM; Gonzalez-Rico C; Vidal E; Torre-Cisneros J; Ras MM; Pérez S; Sabe N; López-Soria LM; Rodríguez-Alvarez RJ; Montejo JM; Valerio M; Machado M; Muñoz P; Linares L; Bodro M; Moreno A; Fernández-Cruz A; Cantón R; Moreno S; Martin-Davila P; Fortún J
    Mycoses; 2021 Nov; 64(11):1334-1345. PubMed ID: 33934405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
    Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
    Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
    Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis.
    Carvalho-Dias VM; Sola CB; Cunha CA; Shimakura SE; Pasquini R; Queiroz-Telles Fd
    Braz J Infect Dis; 2008 Oct; 12(5):385-9. PubMed ID: 19219277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Microbiological Characteristics of Proven Invasive Aspergillosis Due to Rare/Cryptic Species in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Yamamuro R; Kimura M; Asano-Mori Y; Abe M; Nakamura S; Umeyama T; Yamagoe S; Miyazaki Y; Ogura S; Sakoh T; Mitsuki T; Yamaguchi K; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto H; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0163021. PubMed ID: 34780271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
    Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
    Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
    Steinbach WJ; Marr KA; Anaissie EJ; Azie N; Quan SP; Meier-Kriesche HU; Apewokin S; Horn DL
    J Infect; 2012 Nov; 65(5):453-64. PubMed ID: 22898389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.
    Ramos ER; Jiang Y; Hachem R; Kassis C; Kontoyiannis DP; Raad I
    Oncologist; 2011; 16(7):1049-60. PubMed ID: 21659609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
    Linden PK; Coley K; Fontes P; Fung JJ; Kusne S
    Clin Infect Dis; 2003 Jul; 37(1):17-25. PubMed ID: 12830404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.